Anti-Serum Amyloid P 抗体 [EP1018Y] (ab45151)

ab45151 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab45151 は 7 報の論文で使用されています。

  • Helmfors L  et al. Serum Amyloid P Component Ameliorates Neurological Damage Caused by Expressing a Lysozyme Variant in the Central Nervous System of Drosophila melanogaster. PLoS One 11:e0159294 (2016). IHC-P . PubMed: 27428539
  • McCook JP  et al. Ability of sodium copper chlorophyllin complex to repair photoaged skin by stimulation of biomarkers in human extracellular matrix. Clin Cosmet Investig Dermatol 9:167-74 (2016). IHC-P ; Human . PubMed: 27524916
  • Yang G  et al. Isolation and identification of mannose-binding proteins and estimation of their abundance in sera from hepatocellular carcinoma patients. Proteomics 13:878-92 (2013). Human . PubMed: 23300094
  • Crawford JR  et al. Fc?RI mediates serum amyloid P inhibition of fibrocyte differentiation. J Leukoc Biol 92:699-711 (2012). WB . PubMed: 22493081
  • Caubet C  et al. A new amyloidosis caused by fibrillar aggregates of mutated corneodesmosin. FASEB J 24:3416-26 (2010). IHC-P ; Human . PubMed: 20448140
  • Castaño AP  et al. Serum amyloid P inhibits fibrosis through Fc gamma R-dependent monocyte-macrophage regulation in vivo. Sci Transl Med 1:5ra13 (2009). IHC-P ; Human . PubMed: 20368175
  • Gomer RH  et al. A serum amyloid P-binding hydrogel speeds healing of partial thickness wounds in pigs. Wound Repair Regen 17:397-404 (2009). WB . PubMed: 19660048

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録